For years I told patients that heartburn meant too little stomach acid: low acid failed to signal the valve to close, so the fix was to add acid rather than block it. It is a tidy theory. It was tested in people, and it failed. If someone has told you that you have low stomach acid, the useful question is not whether the condition exists. It does. The question is whether you have it, and which test would show it.
The video The Heartburn Pill You Can’t Quit covers the acid-blocker half of the story. What follows is the measurement half: who actually makes too little acid, what symptoms can and cannot tell you, and what repairs the terrain. Both come from The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes.
The experiment that sank the low-acid theory of reflux
Researchers gave heartburn patients seven days of twice-daily omeprazole and counted reflux with impedance, which registers anything moving upward, acid or not. The count did not fall; it went from two hundred and seventeen episodes to 261. Only the chemistry changed. The acid share dropped from 45% to 3%, while the non-acid share climbed from 55% to 97%.
If low acid opened the valve, pushing acid close to zero should have opened it wider. It did not. The hormone theory fared no better. Among 100 patients studied in sequence with pressure and pH recordings, gastrin showed no correlation with reflux scores or valve pressure.
What does open the valve is stretch. A meal pushed the rate of brief valve relaxations in fifteen healthy people from 1.40 to 5.4 an hour in the first half hour. In a crossover trial in healthy men, a drug cut relaxations from 15.0 to 12.0 over three hours while resting valve pressure stayed put, 16.3 against 18.0 mm Hg. Tone and triggering are separate dials, and neither one reads pH.
An acid pool that forms in every healthy stomach
After a meal, a pocket of fresh acid floats on top of the food just below the valve. In nine healthy volunteers without a hernia, it formed in 7 of them, showing up roughly 9 minutes after eating began and lasting about 47 minutes.
The pocket is normal. Its location is the problem. During valve relaxations the pool sat at or above the diaphragm 22% of the time in healthy volunteers, 54% in people with a small hiatus hernia, and 77% with a large one.
That makes reflux a matter of shape and pressure, not chemistry.
Does stomach acid really run low after sixty?
This is the claim that sells the most supplements, and it has been measured. Among 248 volunteers aged 65 and over, 208 had acidic stomach contents at rest, a pH below 3.5. That is 84%. Weighted to the population, 67% secreted acid consistently, 22% intermittently, and 11% consistently made too little.
A study of 41 healthy adults went further. Older subjects produced more acid than younger ones, at rest, after a meal and under stimulation. Age pushed output up independently. H. pylori infection pushed it down.
So low stomach acid after sixty is a minority finding, about one person in nine. For that person it matters a great deal. For the other eight, adding acid treats a problem they do not have,.
The two real causes, and why symptoms cannot find them
True hypochlorhydria has two main routes. In autoimmune gastritis, the immune system destroys the parietal cells that make acid. In H. pylori-driven atrophy, infection thins the lining over years. Atrophic gastritis carries a global prevalence of 25.4%, significantly higher in infected people.
Here the measurement problem bites. Prevalence did not differ between people with symptoms and people without them. How your stomach feels cannot sort you into the right group, and neither can how you feel after a supplement, because comfort is not secretion.
A stomach that has lost its acid for good needs watching, not a bottle. In autoimmune gastritis, stomach adenocarcinoma runs 0.12% to 0.5% a year, and type I neuroendocrine tumors 0.68% to 2.8% a year, reaching 15.3% over five years. The first tests are simple: H. pylori, and pepsinogens, a blood marker of how much acid-making lining remains. They belong in the same metabolic audit that asks whether a body can heal.
What acid protects, and how the tests change the verdict
Acid is a border, the switch that turns on protein digestion, and a filter on what reaches the small intestine. Remove it with a drug and the ecology shifts. How much it seems to shift depends almost entirely on the instrument.
Pooled across 11 studies and 3,134 people, acid suppression carried an odds ratio of 2.282 for small intestinal bacterial overgrowth. Split by method, the answer changed. Studies that cultured fluid drawn straight from the small bowel found 7.587. Studies using the common breath test found 1.93, with an interval that included no effect at all. Same question, different ruler, different verdict.
Infection shows the same pattern. Pooling randomized trials only, C. difficile came out at a relative risk of 1.19 across 8 trials and 29,880 participants, an interval wide enough to include no effect. Observational alarms tend to shrink once patients are randomized.
Protein and B12 are the quieter costs. Pepsin only works in acid, and acid is what releases B12 from food protein. A stomach held at high pH passes both along poorly. For anyone working to protect muscle with protein and resistance training, digestion is part of the dose, and a falling B12 deserves attention long before memory slips.
Putting acid back versus taking pressure off
Betaine hydrochloride does acidify a stomach. In six healthy volunteers whose acid had been suppressed by a drug, it dropped pH below 3 in about 6.3 minutes and kept it under 4 for about 77 minutes. The study was built to help medicines dissolve, not to treat anyone. Apple cider vinegar has no human trial. Either one is mechanism applied by judgment, in a person with a measured reason, never a default.
The repairs with trial-grade support are mechanical. A review that screened 2039 studies found only 16 trials testing a lifestyle measure against a reflux outcome. Weight loss improved both the acid profile and symptoms. Raising the head of the bed and lying on the left side reduced acid exposure. Both work on pressure and gravity, not chemistry.
The pressure has a metabolic source. Abdominal weight raises the gradient across the junction, and the same visceral fat drives insulin resistance and metaflammation. A food system subsidizes the acellular carbohydrates that build that belly, then profits from the pill that manages its pressure. That is why no single intervention outruns a broken metabolism.
Meal timing belongs to the earlier look at eating frequency, and the next one follows a common pain prescription further down the gut. The Deep Dive on stomach acid lists every study behind these figures, with what each one does and does not show.
Frequently asked questions
What are the symptoms of low stomach acid?
No symptom pattern reliably identifies it. In a large review of stomach lining atrophy, the most common route to genuinely low acid, prevalence was the same in people with and without symptoms. Fullness, bloating or heaviness after meals have many causes, so a diagnosis starts with tests rather than a checklist or a trial of supplements. Testing whether the terrain can heal starts with the right panel.
How do you test for low stomach acid?
Start with the two conditions that actually produce it. Testing for H. pylori looks for the infection that thins the stomach lining, and serum pepsinogens reflect how much acid-producing tissue is left. Taking a supplement to see how it feels is not a test, because comfort does not track secretion, and a single normal-looking number can still hide a shortfall. What a normal lab value can conceal.
Should I take betaine HCl for heartburn?
Not as a default. Reflux is driven by pressure and the position of the acid pocket, not by too little acid, and most adults 65 and over still acidify their stomach. The only human study of betaine tested six volunteers on a single dose to help drugs dissolve. For the minority with proven low acid, it is a judgment call made with a physician. Acid is only the first step in a digestive relay that bile continues.
Does stomach acid decrease with age?
Not in healthy people. In one careful study older adults made more acid than young adults, and age had an independent positive effect on output. Low acid in older people usually traces to H. pylori infection or autoimmune damage to the lining, and both can be tested for. Blaming age hides a cause that can be found and addressed. What really changes in the body after fifty.
Can long-term acid blockers cause bacterial overgrowth?
They are associated with it, and the size of the link depends on the test used. Culturing small bowel fluid shows a strong association, while the common breath test shows one that does not reach significance. A later pooled estimate described the effect as moderate. Anyone chasing overgrowth should ask which instrument produced the result before acting on it. Stool reports can point at the wrong culprit entirely.
Test the stomach before you treat it
If you have been told your stomach acid is low without a single test to show it, start with the measurements that separate the minority who need acid from the majority who need less pressure. We build them into the metabolic workup.
Questions? Call (314) 295-3000 or text (314) 886-5902.
Sources
- Vela, M. F., Camacho-Lobato, L., Srinivasan, R., Tutuian, R., Katz, P. O., & Castell, D. O. (2001). Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.. Gastroenterology, 120(7), 1599-606. https://doi.org/10.1053/gast.2001.24840
- Singhartinger, F. X., Wahl, L., Weitzendorfer, M., Gantschnigg, A., Koch, O. O., & Emmanuel, K. (2022). The role of hormones in symptoms and pathophysiology of reflux and esophageal motility disorders.. Zeitschrift fur Gastroenterologie, 61(7), 810-817. https://doi.org/10.1055/a-1833-9494
- Hurwitz, A., Brady, D. A., Schaal, S. E., Samloff, I. M., Dedon, J., & Ruhl, C. E. (1997). Gastric acidity in older adults.. JAMA, 278(8), 659-62. https://pubmed.ncbi.nlm.nih.gov/9272898/
- Goldschmiedt, M., Barnett, C. C., Schwarz, B. E., Karnes, W. E., Redfern, J. S., & Feldman, M. (1991). Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women.. Gastroenterology, 101(4), 977-90. https://doi.org/10.1016/0016-5085(91)90724-y
- Mulder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutierrez-Torres, D. S., Zauber, A. G., O’Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(8), 1605-1617.e46. https://doi.org/10.1016/j.cgh.2024.02.023
- Zhang, T., & Tang, X. (2025). Beyond metaplasia: unraveling the complex pathogenesis of autoimmune atrophic gastritis and its implications for gastric cancer risk.. QJM : monthly journal of the Association of Physicians, 118(4), 203-247. https://doi.org/10.1093/qjmed/hcaf028
- Lo, W.-K., & Chan, W. W. (2013). Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.. Clinical Gastroenterology and Hepatology, 11(5), 483-490. https://doi.org/10.1016/j.cgh.2012.12.011
- Floria, D.-E., Obeidat, M., Váncsa, S., Kávási, S. B., Földvári-Nagy, L., Hegyi, P., Veres, D. S., Drug, V.-L., & Erőss, B. (2025). Proton pump inhibitors are not associated with an increased risk of infection: a systematic review and meta-analysis of randomized controlled trials.. Gut Microbes, 17(1), 2562341. https://doi.org/10.1080/19490976.2025.2562341
- Yago, M. R., Frymoyer, A. R., Smelick, G. S., Frassetto, L. A., Budha, N. R., Dresser, M. J., Ware, J. A., & Benet, L. Z. (2013). Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria.. Molecular Pharmaceutics, 10(11), 4032-4037. https://doi.org/10.1021/mp4003738
- Kaltenbach, T., Crockett, S., & Gerson, L. B. (2006). Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach.. Archives of Internal Medicine, 166(9), 965-971. https://doi.org/10.1001/archinte.166.9.965